{"id": "1339244012327190529", "creation": 1608135629.0, "user_id": "83514808", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}}, "text": "#Covaxin, the #vaccine candidate being developed by #BharatBiotech and #ICMR-National Institute of Virology, induced 'robust' immune response among Phase 1 trial participants. #COVID19 #India #coronavirus #CovidVaccine\n#TheWeek @TheWeekLive https://t.co/0fDQ5JgNmo", "first_save": 1634559108.199414, "hashtags": ["#COVAXIN", "#VACCINE", "#BHARATBIOTECH", "#ICMR", "#COVID19", "#INDIA", "#CORONAVIRUS", "#COVIDVACCINE", "#THEWEEK"]}